NCT03719586: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 112 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03719586 |
|---|---|
| Title | A Multicenter, Multi-Outbreak, Randomized, Controlled Safety and Efficacy Study of Investigational Therapeutics for the Treatment of Patients With Ebola Virus Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 21, 2018 |
| Completion date | Sept. 9, 2019 |
| Required reporting date | Sept. 8, 2020, midnight |
| Actual reporting date | Dec. 30, 2020 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 112 |